Blog

Rare disease research has come a long way thanks in part to the passage of the Orphan Drug Act (ODA) of 1983. In the 40

The last 12 months have been challenging for many in the biopharmaceutical space. Consider that industry layoffs increased 57% in 2023 compared to 2022. It’s

In October 2023, the FDA issued draft guidance on Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities. The document explains how the FDA

Clinical trials are designed to determine if new drugs, therapies, and medical devices are safe and effective for public use. These interventions are tested on

3 Common Barriers to Clinical Trial Enrollment + Tips for Taking Action   Despite all the good that clinical trials provide, patient enrollment is often

Recruiting patients for clinical trials is an expensive and time-consuming process, taking about 18 months on average. It’s no surprise then that many biopharmas and